ADMA Biologics, Inc.
ADMA Biologics, Inc. scores highest on Torque (63) and lowest on Price (48). Its PosiPenta is 56.51 out of 100, around the middle of similar companies.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Details
PPrice
| P/E ratio | 15.64 |
| P/B ratio | 6.01 |
EEarnings
| Trailing EPS | ₹66.07 |
| Forward EPS | ₹89.04 |
NNitro
| Price | 1033.58 |
| 52-week high | 1931.05 |
| 52-week low | 680.56 |
| Fall from 52-week high | 46.5% |
TTorque
| Return on equity (ROE) | 41.90% |
| Debt-to-equity | 0.50 |
AAnchor
| Beta (price swings) | 0.69 |
| Market cap | ₹23,150 Cr |
| Insider holding | 1.97% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is ADMA Biologics, Inc.'s PosiPenta score?
ADMA Biologics, Inc.'s PosiPenta is 56.51 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Which PosiPenta pillar is strongest for ADMA Biologics, Inc.?
Torque (durability), with a score of 63 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for ADMA Biologics, Inc.?
Price (valuation), with a score of 48 out of 100: around the middle of similar companies.
Has ADMA Biologics, Inc.'s PosiPenta changed since last week?
Yes, it fell 0.26 points, from 56.77 to 56.51.
PositoAI is for research and education only and is not investment advice.